Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Comment by Gonzoruleon Jan 21, 2020 12:02pm
54 Views
Post# 30577975

RE:Sausage

RE:Sausage

I'm not qualified to offer a price / opinion based on industry metrics or accepted formulae. I have in the past sold a business though, and in the end - none of those metrics applied. Ultimately the deal was inked after much posturing, show, flash and fanegaling. I got a price 20% over asking, but then ended up overpaying on my next investment

Based on an 'accepted' opinion of how these two operate, I would be inclined to believe the selling price would be based entirely on the perspective of their personal gain, with absolute  disregard for the remaining shareholders

This could be a great opportunity for a buyer who wants in to the industry with a turnkey opportunity, and willing to pay more. There's a lot of added value in THC over and above the tale of the books, that would warrant paying more

I M O - As an ongoing concern:
a good deal for a buyer at .15 to .20
a good deal for Thc (JM/HJC) above .20

I'm a bag holder at .25
 

 

Bullboard Posts